Trade Mark Journal No.2025/028 11 July 2025

UK00004226817 30 June 2025 (5)

ONFARLA

Class 5: Pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, endocrine, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders.

Corcept Therapeutics Incorporated

Representative: Fieldfisher LLP